Bio Green Med Solution, Inc. Asset Resilience Ratio

Latest as of December 2017: 0.51%

Bio Green Med Solution, Inc. asset resilience ratio. Bio Green Med Solution, Inc. (BGMS) has an Asset Resilience Ratio of 0.51% as of December 2017. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See defensive interval ratio of Bio Green Med Solution, Inc. to measure how many days the company can operate on defensive assets alone.

Liquid Assets

$132.00K
Cash + Short-term Investments

Total Assets

$26.00 Million
All company assets

Resilience Assessment

Low
Financial Resilience Level

Asset Resilience Ratio of Bio Green Med Solution, Inc. (2005–2017)

Asset resilience ratio of Bio Green Med Solution, Inc. from 2005 to 2017. This chart shows how Bio Green Med Solution, Inc.'s Asset Resilience Ratio has changed over time. Read BGMS total liabilities for a breakdown of total debt and financial obligations.

Liquid Assets Composition Over Time

This chart breaks down Bio Green Med Solution, Inc.'s liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see BGMS total assets.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents $0.00 0%
Short-term Investments $132.00K 0.51%
Total Liquid Assets $132.00K 0.51%

Asset Resilience Insights

  • Limited Liquidity: Bio Green Med Solution, Inc. maintains only 0.51% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company has significant short-term investments, indicating active treasury management.

Bio Green Med Solution, Inc. Industry Peers by Asset Resilience Ratio

Compare Bio Green Med Solution, Inc.'s asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Hyloris Developmentsen Sa
BR:HYL
Biotechnology 1.36%
Biomarin Pharmaceutical Inc
NASDAQ:BMRN
Biotechnology 0.00%
Oruka Therapeutics, Inc.
NASDAQ:ORKA
Biotechnology 53.11%
Gempharmatech Co. Ltd. A
SHG:688046
Biotechnology 23.95%
Vor Biopharma Inc
NASDAQ:VOR
Biotechnology 74.48%
Inventiva S.A
PA:IVA
Biotechnology 52.73%
Sunmax Biotechnology Co Ltd
TWO:4728
Biotechnology 10.53%
Guangdong VTR Bio-Tech Co Ltd
SHE:300381
Biotechnology 4.98%

Bio Green Med Solution, Inc. Asset Resilience Ratio by Year (2005–2017)

Bio Green Med Solution, Inc. asset resilience ratio by year from 2005 to 2017. The table below shows the annual Asset Resilience Ratio data for Bio Green Med Solution, Inc..

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2017-12-31 0.51% $132.00K $26.00 Million -0.16pp
2016-12-31 0.67% $132.00K $19.66 Million +0.14pp
2015-12-31 0.53% $132.00K $24.76 Million +0.08pp
2014-12-31 0.45% $132.00K $29.39 Million -63.22pp
2012-12-31 63.67% $12.32 Million $19.35 Million -12.85pp
2011-12-31 76.52% $19.89 Million $26.00 Million -15.87pp
2010-12-31 92.39% $29.07 Million $31.46 Million +33.66pp
2009-12-31 58.74% $8.50 Million $14.47 Million -9.56pp
2008-12-31 68.29% $21.14 Million $30.96 Million -1.98pp
2007-12-31 70.27% $53.34 Million $75.91 Million +16.12pp
2006-12-31 54.15% $34.26 Million $63.28 Million -1.90pp
2005-12-31 56.05% $10.69 Million $19.07 Million --
pp = percentage points

About Bio Green Med Solution, Inc.

NASDAQ:BGMS USA Biotechnology
Market Cap
$4.81 Million
Market Cap Rank
#28599 Global
#5881 in USA
Share Price
$0.87
Change (1 day)
-3.11%
52-Week Range
$0.60 - $1.82
All Time High
$5.95
About

Bio Green Med Solution, Inc. engages in the distributing, trading, and installation of protective and fire safety materials and equipment, and fire protection and prevention systems. It is also involved in research and development of pharmaceuticals. The company was formerly known as Cyclacel Pharmaceuticals, Inc. and changed its name to Bio Green Med Solution, Inc. in September 2022. Bio Green M… Read more